Analysis of the incidence of new coronavirus infection in oncological patients on the example of the oncological department of anticancer drug therapy of the Bashkir State Medical University

N. O Yuldasheva; Юлдашева Н. О; Regina I. Kunafina; Кунафина Р. И; D. D Sakaeva; Сакаева Д. Д; D. E Baikov; Байков Д. Э; R. R Suleymanova; Сулейманова Р. Р

doi:10.18565/pharmateca.2020.11.52-54

Analysis of the incidence of new coronavirus infection in oncological patients on the example of the oncological department of anticancer drug therapy of the Bashkir State Medical University

Authors: Yuldasheva N.O¹, Kunafina R.I.¹, Sakaeva D.D¹, Baikov D.E¹, Suleymanova R.R¹
Affiliations:
1. Bashkir State Medical University, BSMU Clinic
Issue: Vol 27, No 11 (2020)
Pages: 52-54
Section: Articles
URL: https://journals.eco-vector.com/2073-4034/article/view/312875
DOI: https://doi.org/10.18565/pharmateca.2020.11.52-54
ID: 312875

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription or Fee Access

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

Follow-up of oncological patients with coronavirus infection requires careful monitoring. Currently, there is no reliable national statistics on morbidity among patients with oncopathologies, as well as information on the features of the course of the disease. In our opinion, such an exchange of information is extremely important in order to properly organize work in the context of the COVID-19 pandemic.

Keywords

coronavirus infection, viral pneumonia, oncological patients